Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ACTRN12618000512224
ACTRN12618000512224Recruiting未知

Self-other processing in first-episode psychosis: a high-definition transcranial direct current stimulation study

The University of Queensland0 sites60 target enrollmentStarted: April 9, 2018Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
60
Study OverviewStudy DesignEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 35 Years (—)
Sex
All

Inclusion Criteria

  • •First episode psychosis patients who are Caucasian with English as first language.

Exclusion Criteria

  • •Neurological disease/trauma (including seizures/migraine)
  • •Non-Caucasian
  • •Substantial current substance abuse
  • •Medical devices not compatible with transcranial direct current stimulation

Investigators

Similar Trials

Recruiting
Not Applicable
Recovery and Relapse in Early PsychosisMental and behavioral disorders
KCT0001605Chonbuk National University Hospital210
Withdrawn
Not Applicable
Improving cognition in Early Psychosis using Transcranial Magnetic StimulatioSchizophrenia
ACTRN12620000504910QIMR Berghofer Medical Research Institute35
Recruiting
Phase 3
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trialinvestigating the efficacy of N-Acetylcysteine (NAC) and Integrated Preventive PsychologicalIntervention (IPPI) in Subjects Clinically at High Risk for PsychosisSubjects presenting ultra-high risk (UHR) for psychosis (e.g. attenuated psychotic symptoms, brief limited intermittend psychotic symptoms or a genetic risk in combination with a decline in social functioning)
DRKS00010952Zentralinstitut für seelische Gesundheit/Central Institute of Mental Health (ZI)200
Active, not recruiting
Phase 1
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trial investigating the efficacy of Acetylcysteine (ACC) and Integrated Preventive Psychological Intervention (IPPI) in Subjects Clinically at High Risk for Psychosis
EUCTR2014-003076-22-DECentral Institute of Mental Health Mannheim (ZI)130
Recruiting
Not Applicable
Emotion-Cognition Interaction in Psychotic Disorderspsychosis10039628Schizophrenia
NL-OMON33944Erasmus MC, Universitair Medisch Centrum Rotterdam120